Investing Profile

Laurence Barker

InvestorVC
Partner at SV Dementia Discovery Fund (DDF) at SV Health Investors' Dementia Discovery Fund (DDF)
Photo of Laurence Barker, Partner at SV Health Investors' Dementia Discovery Fund (DDF)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4974 CONNECTIONS
GSK Network
45 CONNECTIONS
GSK Network
45 CONNECTIONS
GSK Network
45 CONNECTIONS
University of Auckland Network
11 CONNECTIONS
cb
$100K - $1.5M
$1.5M
11
CompanyStageDateRound SizeTotal Raised
TRIMTECH Therapeutics
SeedJun 2026$14M
SeedMar 2025$31M
$45M
Co-investors: Jeffrey Moore (MP Healthcare Venture Management), Hakan Goker (MDC Ventures (formerly KBS Ventures)), Michael Anstey (Cambridge Innovation Capital)
Cerevance
Series CMay 2026$20M
Series BFeb 2023$51M
$180M
Co-investors: David Schenkein (GV (Google Ventures)), Bill Gates (Breakthrough Energy Ventures), Kouki Harasaki (M12 - Microsoft's Venture Fund), Jason Lettmann (Morgenthaler Ventures)
NRG Therapeutics
Series BSep 2025$68M
$86M
Co-investors: Jonathan Tobin (Brandon Capital Partners), Florian Müllershausen (Novartis Venture Fund)
Therini Bio
Series AMay 2025$39M
Series AApr 2023$36M
SeedMay 2021$17M
SeedJul 2019$9M
$100M
Co-investors: Jim Trenkle (Sanofi Ventures), Mike Ross (SV Health Investors), Pascal Levensohn (Levensohn Venture Partners), Houman Ashrafian (SV Health Investors)
AstronauTx
Series AOct 2023$59M
$60M
Co-investors: Simon Goldman (AlbionVC), Jonathan Tobin (Brandon Capital Partners), Marianne Uteng (Novartis Venture Fund)
Amathus Therapeutics
Series UnknownSep 2019
MSc Student HortResearchPresent
Project Manager HotmailPresent
Associate Director Business Development MorphoSysPresent
Head of Business Development Syntaxin LtdPresent
Director, Transactions, Worldwide Business Development GSKPresent
Senior Director, Transactions & Investment Management, Worldwide Business Development GSKPresent
Head of Investment Management, Worldwide Business Development GSKPresent
Partner at Dementia Discovery Fund - SV Health Investors SV Health Investors' Dementia Discovery Fund (DDF)Present
Partner at SV Dementia Discovery Fund (DDF) SV Health Investors' Dementia Discovery Fund (DDF)Present
University of Auckland MSc Biochemistry, Molecular Biology
The University of Auckland MSc Biochemistry, Molecular Biology
Eberhard Karls Universität Tübingen PhD Biochemistry, Molecular Biology
University of Tübingen PhD Biochemistry, Molecular Biology
Sign in with Google →
Sign in with Google →